A phase I trial of sorafenib combined with cisplatin/etoposide or carboplatin/pemetrexed in refractory solid tumor patients Article

cited authors

  • Davies, Janine M.; Dhruva, Nirav S.; Walko, Christine M.; Socinski, Mark A.; Bernard, Stephen; Hayes, D. Neil; Kim, William Y.; Ivanova, Anastasia; Keller, Kimberly; Hilbun, Layla R.; Chiu, Michael; Dees, E. Claire; Stinchcombe, Thomas E.

authors

Publication Date

  • February 1, 2011

webpage

published in

category

keywords

  • Non-small cell lung cancer
  • Phase I
  • Safety and toxicity
  • Small cell lung cancer
  • Sorafenib

start page

  • 151

end page

  • 155

volume

  • 71

issue

  • 2